Marquette Asset Management »

Nektar Therapeutics shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $105k 186k 0.57
2023-09-30 $88k 148k 0.60
2023-06-30 $85k 148k 0.58

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Us Aggbd Et (AGG)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Ser Tr S&p Kensho New (KOMP)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Rus 1000 Val Etf (IWD)
First Tr Dow Jones Select Mi Com Shs Annual (FDM)

View all positions for Marquette Asset Management

Top funds holding Nektar Therapeutics

Vanguard Group
PRIMECAP Management Company
Monaco Asset Management SAM
Citadel Advisors
D. E. Shaw & Co
Alyeska Investment Group
Jacobs Levy Equity Management
Two Sigma Advisers
Marshall Wace
Tang Capital Management
Two Sigma Investments
GSA Capital Partners
Lynx1 Capital Management
Assenagon Asset Management
Millennium Management

View all funds holding Nektar Therapeutics